These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9006094

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. DNA excision-repair synthesis is enhanced in a murine leukemia L1210 cell line resistant to cisplatin.
    Calsou P, Barret JM, Cros S, Salles B.
    Eur J Biochem; 1993 Feb 01; 211(3):403-9. PubMed ID: 8436104
    [Abstract] [Full Text] [Related]

  • 23. Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells.
    Kido Y, Khokhar AR, Siddik ZH.
    Biochem Pharmacol; 1994 Apr 29; 47(9):1635-42. PubMed ID: 8185678
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Repair of ribosomal RNA genes in hamster cells after UV irradiation, or treatment with cisplatin or alkylating agents.
    Stevnsner T, May A, Petersen LN, Larminat F, Pirsel M, Bohr VA.
    Carcinogenesis; 1993 Aug 29; 14(8):1591-6. PubMed ID: 8353843
    [Abstract] [Full Text] [Related]

  • 26. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.
    Hill BT, Shellard SA, Hosking LK, Fichtinger-Schepman AM, Bedford P.
    Int J Radiat Oncol Biol Phys; 1990 Jul 29; 19(1):75-83. PubMed ID: 2380098
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M, Khokhar AR, Siddik ZH.
    Cancer Res; 1994 Sep 01; 54(17):4691-7. PubMed ID: 8062266
    [Abstract] [Full Text] [Related]

  • 29. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS, Mills GB, Khokhar AR, Bast RC, Siddik ZH.
    Clin Cancer Res; 1999 Mar 01; 5(3):655-63. PubMed ID: 10100719
    [Abstract] [Full Text] [Related]

  • 30. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines.
    Yoshida M, Khokhar AR, Siddik ZH.
    Anticancer Drug Des; 1994 Oct 01; 9(5):425-34. PubMed ID: 7945726
    [Abstract] [Full Text] [Related]

  • 31. Limitations of the in vitro repair synthesis assay for probing the role of DNA repair in platinum resistance.
    Nichols AF, Schmidt WJ, Chaney SG, Sancar A.
    Chem Biol Interact; 1992 Feb 01; 81(3):223-31. PubMed ID: 1540994
    [Abstract] [Full Text] [Related]

  • 32. Oxaliplatin: mechanism of action and antineoplastic activity.
    Raymond E, Faivre S, Woynarowski JM, Chaney SG.
    Semin Oncol; 1998 Apr 01; 25(2 Suppl 5):4-12. PubMed ID: 9609103
    [Abstract] [Full Text] [Related]

  • 33. Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines.
    Johnson SW, Perez RP, Godwin AK, Yeung AT, Handel LM, Ozols RF, Hamilton TC.
    Biochem Pharmacol; 1994 Feb 11; 47(4):689-97. PubMed ID: 8129746
    [Abstract] [Full Text] [Related]

  • 34. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH, Thai G, Yoshida M, Zhang YP, Khokhar AR.
    Anticancer Drug Des; 1994 Dec 11; 9(6):495-509. PubMed ID: 7880375
    [Abstract] [Full Text] [Related]

  • 35. Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines.
    Moufarij MA, Phillips DR, Cullinane C.
    Mol Pharmacol; 2003 Apr 11; 63(4):862-9. PubMed ID: 12644587
    [Abstract] [Full Text] [Related]

  • 36. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs.
    Hacker MP, Khokhar AR, Brown DB, McCormack JJ, Krakoff IH.
    Cancer Res; 1985 Oct 11; 45(10):4748-53. PubMed ID: 4040806
    [Abstract] [Full Text] [Related]

  • 37. Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat.
    To KK, Tong WS, Fu LW.
    Lung Cancer; 2017 Jan 11; 103():58-65. PubMed ID: 28024697
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system.
    Perego P, Caserini C, Gatti L, Carenini N, Romanelli S, Supino R, Colangelo D, Viano I, Leone R, Spinelli S, Pezzoni G, Manzotti C, Farrell N, Zunino F.
    Mol Pharmacol; 1999 Mar 11; 55(3):528-34. PubMed ID: 10051537
    [Abstract] [Full Text] [Related]

  • 40. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF, Koberle B, Masters JR, Kelland LR.
    Br J Cancer; 1999 Dec 11; 81(8):1294-303. PubMed ID: 10604725
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.